SNDX - Syndax Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1,220627-
Cost of Revenue---
Gross Profit1,220627-
Operating Expenses
Research Development31,6659,54910,175
Selling General and Administrative13,32111,59111,157
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-43,766-20,513-21,332
Income from Continuing Operations
Total Other Income/Expenses Net-1,662-2,1921,793
Earnings Before Interest and Taxes-44,472-24,119-19,828
Interest Expense---
Income Before Tax-44,472-24,119-19,828
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-44,472-24,119-19,828
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-44,472-24,119-19,828
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-47,070-103,845-26,357